Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie Inc    ABBV

ABBVIE INC (ABBV)

Delayed Quote. Delayed  - 07/22 10:00:20 pm
63.81 USD   -0.13%
07/14 ABBVIE : Student's art blooms despite chronic condition
07/13 ABBVIE : ex-dividend day
07/12 Lower-cost biotech drug gets thumbs up from FDA panel
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
63.56(c) 63.32(c) 63.41(c) 63.89(c) 63.81(c) Last
6 384 755 5 794 503 7 502 821 6 515 660 4 908 506 Volume
+0.38% -0.38% +0.14% +0.76% -0.13% Change
More quotes
Financials ($)
Sales 2016 25 473 M
EBIT 2016 10 686 M
Net income 2016 6 671 M
Debt 2016 27 901 M
Yield 2016 3,56%
Sales 2017 27 980 M
EBIT 2017 12 255 M
Net income 2017 8 219 M
Debt 2017 25 596 M
Yield 2017 3,89%
P/E ratio 2016 15,63
P/E ratio 2017 12,28
EV / Sales2016 5,15x
EV / Sales2017 4,60x
Capitalization 103 204 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and... 
Sector
Pharmaceuticals
Calendar
07/29 | 01:00pmEarnings Release
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
07/15 ABBVIE : Researchers Submit Patent Application, "Devices and Methods for Deliver..
07/14 ABBVIE : Study Findings from AbbVie Inc. Provide New Insights into Ankylosing Sp..
07/14 ABBVIE : Student's art blooms despite chronic condition
07/13 ABBVIE : ex-dividend day
07/12 Lower-cost biotech drug gets thumbs up from FDA panel
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12 ABBVIE : Fresh from Boehringer R&D tie-up, Inventiva to go public on Euronext
07/11 Psoriasis Market with Focus on Plaque Psoriasis Global Industry Analysis with..
07/07 INFINITY PHARMACEUTICALS : Regains Worldwide Rights To Duvelisib Following Mutua..
07/07 ABBVIE : to Host Second-Quarter Earnings Conference Call
More news
Sector news : Specialty & Advanced Pharmaceuticals
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE INC 
2015A likely recovery
More Strategies
News from SeekingAlpha
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/22 BIOGEN BEATS, RAISES : Bye, Bye Bear Move, Hello Bull?
07/21 Big Pharma Dominates Healthcare But Caregivers Are Top Sector Yield Dogs In J..
07/20 ELI LILLY : Executive Compensation And Other Metrics
07/19 A 'Better Than Average' Dividend Stock Screening System
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 69,9 $
Spread / Average Target 9,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Azita Saleki-Gerhardt Senior Vice President-Operations
William J. Chase Chief Financial Officer & Executive Vice President
Michael E. Severino Chief Scientific Officer & Executive VP
Robert J. Alpern Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC7.71%103 204
BIOGEN INC-6.06%63 059
MERCK KGAA8.81%13 824
KYOWA HAKKO KIRIN CO L..-0.10%10 328
JAZZ PHARMACEUTICALS P..1.00%8 587
MALLINCKRODT PLC-10.91%7 269
More Results